Skip to content

Esophagitis Eosinophilic 2 C3150679

Published: July 22, 2026Updated: August 20, 2026

A condition where white blood cells accumulate in the esophagus, often triggered by food or environmental allergens.

Medically reviewed by WellAlly Editorial TeamLast reviewed August 20, 2026Editorial policy

Key facts at a glance

ICD-10
K76.9
ICD-11
DA00.0
Body system
gastrointestinal
Severity
moderate
Chronic
true

Signs and symptoms

Common signs and symptoms that may indicate this condition.

Abdominal pain or nausea

(gastrointestinal)

Noticeable symptoms that may vary in intensity over time.

Frequency: Common at all stages

Dysphagia

(gastrointestinal)

Refractory acid reflux

(gastrointestinal)

Nausea

(gastrointestinal)

Food allergy or skin rash

(gastrointestinal)

Diagnosis and tests

How this condition is diagnosed and what test results mean.

Initial screening tests

1

Standard diagnostic workup

Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]

Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]

Treatment options

Evidence-based approaches to managing this condition.

First-line treatments

1

GI disease management

Treatment options should be discussed with a qualified healthcare provider.

lifestyle
2

Proton pump inhibitor

High-dose PPI therapy reduces esophageal acid exposure and modulates local immune responses, decreasing eosinophilic inflammation in the esophageal mucosa. Response rates vary and may require endoscopic verification.

medication
3

Swallowed topical corticosteroids

Viscous budesonide or fluticasone preparations applied directly to esophageal mucosa provide potent anti-inflammatory effects with minimal systemic absorption, reducing eosinophil counts and improving endoscopic appearance.

medication

Additional treatment options

Targeted elimination diet

Diet therapy removing specific identified food allergens based on allergy testing or empiric elimination of common triggers allows esophageal healing while maintaining varied nutrition. Individualized based on patient-specific sensitivities.

dietary

Montelukast therapy

Leukotriene receptor antagonists like montelukast may reduce eosinophil chemotaxis and activation in some patients, providing an adjunctive option when first-line therapies are partially effective.

complementary

Endoscopic surveillance

Periodic upper endoscopy with esophageal biopsies monitors treatment response, assesses for fibrostenotic remodeling, and guides ongoing management decisions. Frequency individualized based on disease severity and treatment response.

monitoring

When to seek medical help

Recognize when you need immediate medical attention.

Schedule an appointment soon

Symptoms associated with this condition. Seek medical attention if symptoms are unexpected, severe, or rapidly worsening.- Contact your healthcare provider if symptoms persist or worsen. Seek emergency care for sudden severe symptoms.

Frequently asked questions

Common questions about this topic.

Q

What is Esophagitis Eosinophilic 2 C3150679?

Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]

general

Sources and references

Authoritative medical sources used to create this content.

1

Dellon ES, Hirano I, Furuta GT. AGA Institute and CAG Clinical Practice Guideline for the Diagnosis and Management of Eosinophilic Esophagitis. Gastroenterology. 2021;161(2):505-525.

guideline2021
2

Lucendo AJ, Molina-Infante J, Arias Á, et al. Efficacy of Dietary Therapies for Inducing Histologic and Clinical Remission in Eosinophilic Esophagitis: A Systematic Review and Meta-Analysis. Gastroenterology. 2019;156(7):1938-1953.

meta_analysis2019
3

Straumann A, Degen L, Felder S, et al. Budesonide Effervescent Tablets for Induction of Remission in Active Eosinophilic Esophagitis: A Randomized, Double-Blind, Placebo-Controlled Trial. Gastroenterology. 2020;159(5):1672-1685.

clinical_trial2020
4

Furuta GT, Katzka DA. Eosinophilic Esophagitis. N Engl J Med. 2015;373(17):1640-1648. (Updated 2023)

review2023

Medication Comparisons

Compare medications used to treat Esophagitis Eosinophilic 2 C3150679. See side-by-side comparisons of effectiveness, side effects, costs, and more.

View Medication Comparisons

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 20, 2026. · Read our editorial policy